CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company’s existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company’s revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securi ...

Encompass Q3 Earnings 1 Forward-Looking Statements and Use of Non-GAAP Financial Measures and Key Performance Indicators Forward-Looking Statements This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Statements regarding the Company's future results of operations and financial position, business strategy and plans ...

Financial Performance Highlights - GoHealth achieved record revenue of $877 million for FY 2020, representing a 63% increase year-over-year[7, 12] - Adjusted EBITDA for FY 2020 reached $271 million, a 59% increase compared to the previous year[7, 12] - The Adjusted EBITDA margin for FY 2020 was 31%[8, 12] - Q4 2020 revenue was $446 million, a 55% increase year-over-year[12] - Q4 2020 Adjusted EBITDA was $170 million, a 31% increase year-over-year, with a 38% margin[12, 27] Growth and Efficiency - Total submissions for FY 2020 were 730,000, a 71% increase year-over-year[6, 12] - Medicare-Internal segment revenue growth was 110% for FY 2020 and 75% for Q4 2020[12] - The company's commissions receivable balance grew by 112% to $810 million in 2020[29, 31] Outlook for 2021 - Projected revenue for FY 2021 is estimated to be between $1.15 billion and $1.3 billion, representing a growth of 31% to 48%[14] - Adjusted EBITDA for FY 2021 is projected to be between $345 million and $385 million, a growth of 27% to 42%[14] - The Adjusted EBITDA margin for FY 2021 is expected to be around 30%[14]

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) complied with federal securities laws. On May 1, 2025, the Department of Justice filed a complaint against GoHealth and others alleging that the Company, among other things, “knowingly entered into unlawful agreements to present false or fraudulent claims to the Government and performed acts in furtherance of this conspiracy.” Following this news, the price of ...

GoHealth (GOCO) Conference Summary Company Overview - GoHealth specializes in helping Medicare consumers navigate their insurance options, particularly Medicare Advantage plans, which are growing rapidly in the market [4][15] - The company has been in operation for over 20 years and has facilitated over 30 million shopping experiences for Medicare consumers [9] Core Business Model - GoHealth provides a personalized shopping experience for Medicare consumers, focusing on their specific healthcare needs, such as doctor networks and drug coverage [7][10] - The company operates primarily through a telephonic model, where 100% of enrollments occur via live conversations with licensed agents [14] Market Dynamics - The Medicare Advantage market is growing at a rate of 5-7% annually, with approximately 68 million consumers in Medicare, half of whom are enrolled in Medicare Advantage plans [15][16] - Over 11,000 new Medicare consumers enter the market daily, with a majority opting for Medicare Advantage plans [16] Competitive Advantage - GoHealth claims to have the lowest customer acquisition cost (CAC) in the industry, being 17% better than public peers and nearly 50% better than the industry average [37] - The company utilizes a proprietary Plan Fit tool that leverages data from 30 million shopping experiences to match consumers with the best insurance plans [33][40] Recent Challenges and Strategic Adjustments - The company has faced challenges due to health plans being tentative about growth under the current economic model, leading to a pullback in writing new Medicare Advantage business [46][47] - GoHealth is diversifying its offerings by introducing guaranteed acceptance life insurance to stabilize agent productivity during slower periods in the Medicare market [55][58] Financial Performance - GoHealth reported material improvements in revenue and adjusted EBITDA for Q1 2024 compared to Q1 2025, driven by efficient resource deployment and an acquisition [38] - The company is working on resetting covenants with lenders due to changes in its business model and market dynamics [49][53] Future Outlook - The upcoming Annual Enrollment Period (AEP) is expected to be highly disruptive, which could lead to increased demand for GoHealth's services as consumers seek new plans [66][68] - The company anticipates a significant increase in revenue from its life insurance business in Q2 and Q3 2025 [63] Key Differentiators - GoHealth emphasizes an unbiased shopping experience, ensuring that agents recommend the best plans for consumers, even if it means advising them to stay on their current plans [21][27] - The company focuses on building long-term relationships with consumers, expecting them to return for multiple shopping experiences throughout their Medicare tenure [30] Conclusion - GoHealth is positioned in a growing market with a unique business model that prioritizes consumer needs and leverages technology to enhance efficiency and customer experience [39][88]

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided. GoHealth, Inc. (NASDAQ:GOCO) On May 1, 2025, t ...

NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen ...

We initiate coverage on GoHealth, Inc. (NASDAQ: NASDAQ: GOCO ) with a Strong Buy and $20 PT. GoHealth is a leading digital Medicare & health insurance brokerage marketplace utilizing AI-based plan optimization and consumer activation in the U.S. Our Strong Buy rating isMoretus Research delivers state-of-the-art, buy-side quality equity research for serious investors seeking clarity, conviction, and alpha. Focused on U.S. public markets, Moretus applies a structured, repeatable framework to identify companie ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GoHealth, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased GoHealth securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GoHealth [2]. Group 2: Allegations and Stock Impact - The U.S. Department of Justice announced charges against GoHealth, alleging that from 2016 to 2021, the company was involved in illegal kickbacks totaling hundreds of millions of dollars to brokers for enrollments in Medicare Advantage plans [3]. - Following the announcement of these charges, GoHealth's stock price dropped by 10.3% on May 1, 2025, and an additional 6.7% on May 2, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4].

WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is investigating GoHealth, Inc. (NASDAQ: GOCO) and certain of its officers and/or directors for potential securities fraud or other securities violations following a complaint recently filed by the Department of Justice alleging unlawful business practices involving a Medicare Advantage kickback scheme. If you are an investor in GoHealth, Inc. and purchased shares of GoHealth between 2016 and May 1, 2025, please consider contact ...